Clinical Trial Update: The Feasibility and Efficacy of Dose Timing (Morning vs Evening) of Temozolomide in the Treatment of Glioblastoma [NA]

View source ↗

Summary

This clinical trial will assess whether administering temozolomide in the morning versus the evening is feasible and potentially more effective for patients wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma
• Idh-wildtype Glioblastoma

Drugs mentioned

• Temozolomide (Temozolomide)

Snippet

Sponsor: Ottawa Hospital Research Institute | Conditions: IDH-Wildtype Glioblastoma, Glioblastoma (GBM) | NA | Status: RECRUITING